Figure 6.
Overall response rates and disease control rates obtained with first-line afatinib in the noninterventional GIDEON study [59] (adapted from Brueckl et al., ESMO, 2018).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.